Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin
The Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM (European Directorate for the Quality of Medici...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar
2015-12-01
|
Series: | Medicamentul Veterinar |
Online Access: | http://www.veterinarypharmacon.com/docs/1600-2015_VD2_Art.8_ENG..pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839604673382711296 |
---|---|
author | Simona Sturzu Daniela Tîrsînoagă Ioana Tihulcă Mariana Dumitrache Alina Drăghici Valentina Năstase |
author_facet | Simona Sturzu Daniela Tîrsînoagă Ioana Tihulcă Mariana Dumitrache Alina Drăghici Valentina Năstase |
author_sort | Simona Sturzu |
collection | DOAJ |
description | The Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM (European Directorate for the Quality of Medicines) - coordinating of the study. The purpose of the study was to establish the potency of the batch 4 rifamycin in the characterization of the substance as reference standard. Potency was determined by
microbiological method, based on comparison of the inhibition zones of growth of micro-organisms sensitive to those of a reference standard, as specified in European Pharmacopoeia, Chapter 2.7.2. - Microbiological testing of antibiotics. After analysis of received data from participants and their statistical processing by the EDQM, the potency of the batch 4, rifamycin - reference materials, was established in 870 UI/mg. |
format | Article |
id | doaj-art-199853ab52d24d8c84b5764a9ec0cae6 |
institution | Matheson Library |
issn | 1843-9527 2069-2463 |
language | English |
publishDate | 2015-12-01 |
publisher | Asociaţia Naţională a Fabricanţilor de Produse de Uz Veterinar |
record_format | Article |
series | Medicamentul Veterinar |
spelling | doaj-art-199853ab52d24d8c84b5764a9ec0cae62025-08-02T02:28:20ZengAsociaţia Naţională a Fabricanţilor de Produse de Uz VeterinarMedicamentul Veterinar1843-95272069-24632015-12-01927779Report concerning the colaborative study for establish of reference standard eficacity of RifamycinSimona Sturzu0Daniela Tîrsînoagă1Ioana Tihulcă2Mariana Dumitrache3Alina Drăghici4Valentina Năstase 5Institute for Control of Veterinary Biological Products and Medicines Bucharest Institute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestInstitute for Control of Veterinary Biological Products and Medicines BucharestThe Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM (European Directorate for the Quality of Medicines) - coordinating of the study. The purpose of the study was to establish the potency of the batch 4 rifamycin in the characterization of the substance as reference standard. Potency was determined by microbiological method, based on comparison of the inhibition zones of growth of micro-organisms sensitive to those of a reference standard, as specified in European Pharmacopoeia, Chapter 2.7.2. - Microbiological testing of antibiotics. After analysis of received data from participants and their statistical processing by the EDQM, the potency of the batch 4, rifamycin - reference materials, was established in 870 UI/mg.http://www.veterinarypharmacon.com/docs/1600-2015_VD2_Art.8_ENG..pdf |
spellingShingle | Simona Sturzu Daniela Tîrsînoagă Ioana Tihulcă Mariana Dumitrache Alina Drăghici Valentina Năstase Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin Medicamentul Veterinar |
title | Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin |
title_full | Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin |
title_fullStr | Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin |
title_full_unstemmed | Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin |
title_short | Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin |
title_sort | report concerning the colaborative study for establish of reference standard eficacity of rifamycin |
url | http://www.veterinarypharmacon.com/docs/1600-2015_VD2_Art.8_ENG..pdf |
work_keys_str_mv | AT simonasturzu reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin AT danielatirsinoaga reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin AT ioanatihulca reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin AT marianadumitrache reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin AT alinadraghici reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin AT valentinanastase reportconcerningthecolaborativestudyforestablishofreferencestandardeficacityofrifamycin |